Picture This: The Current State of OFEV® (nintedanib) capsules and the Role of Radiology

October 17 from 12:30 pm 1:15 pm CDT

Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Please join expert faculty Ayodeji Adegunsoye, MD, and Jonathan Chung, MD, as they discuss the current state of OFEV, focusing on the critical role of radiology during the patient journey. Faculty will discuss the safety and efficacy of OFEV, case studies, and recent guideline updates.

This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2022 conference sessions. This event is not an endorsement by CHEST and does not reflect the views or opinions of CHEST.

This presentation is sponsored by and made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. Presentation content has been reviewed for consistency with FDA guidelines. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.

Speakers

Jonathan H. Chung, MD
University of Chicago
Cardiopulmonary Imaging
Section Chief, Vice Chair of Quality, Professor of Radiology
Chicago, Illinois

Ayodeji Adegunsoye, MD, MS, FCCP
University of Chicago
Pulmonary & Critical Care Medicine
Assistant Professor of Medicine
Chicago, Illinois